Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01553149
Previous Study | Return to List | Next Study

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

This study has suspended participant recruitment.
(Temporarily stopped for assessment. Contact for specifics)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: March 10, 2012
Last updated: October 19, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)